# A Dose Finding Study of Topically Applied I-020201 as an Adjunct to Good Standard-of-care in Patients With Chronic Diabetic Foot Ulcers

> **NCT00915486** · PHASE2 · COMPLETED · sponsor: **Kuros Biosurgery AG** · enrollment: 211 (actual)

## Conditions studied

- Diabetic Foot Ulcer

## Interventions

- **PROCEDURE:** Good Standard of Care (GSoC)
- **BIOLOGICAL:** Vehicle
- **BIOLOGICAL:** I-020201

## Key facts

- **NCT ID:** NCT00915486
- **Lead sponsor:** Kuros Biosurgery AG
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-05
- **Primary completion:** 2012-03
- **Final completion:** 2012-03
- **Target enrollment:** 211 (ACTUAL)
- **Last updated:** 2012-03-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00915486

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00915486, "A Dose Finding Study of Topically Applied I-020201 as an Adjunct to Good Standard-of-care in Patients With Chronic Diabetic Foot Ulcers". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00915486. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*